Cure My Disease

Don't miss your cure!

 Log in / Sign up

Decades of data: how HIV patients fare on Long-Term treatment

NCT ID NCT03296202

Knowledge-focused Sponsor: University Hospital, Bordeaux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This long-term study follows 7,500 adults with HIV who are taking antiretroviral therapy. Researchers track their health over time to understand complications, side effects, and how the infection evolves. The goal is to improve monitoring and care for people living with HIV.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand the long-term health of people living with HIV and improve monitoring and treatment strategies.
What could go wrong
This is an observational study, not a treatment trial. It will not test new drugs or interventions, so it cannot directly lead to a cure or new therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 7,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2017

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients infected with HIV-1 (PLHIV)

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged over 18 years old. * Confirmed HIV infection * Signed informed consent Exclusion Criteria: * HIV-2 infection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antiretroviral agents are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Antiretroviral agents HIV infections

Contacts and locations

Locations

  • Médecine Interne - CH de Jonzac

    Jonzac, France

  • Médecine Interne - CH de Saint-Jean-D'Angely

    Saint-Jean-d'Angély, France

  • Médecine Interne - CH de Saintonge

    Saintes, France

  • Médecine interne - CH d'Angoulême

    Angoulême, France

  • Médecine interne - CH de Royan

    Royan, France

  • Médecine interne et Maladies Infectieuses - CHU de Poitiers

    Poitiers, France

  • Service D'Urgences Pédiatriques

    Bordeaux, France

  • service de maladies infectieuses - CH de la Côte Basque

    Bayonne, 64109, France

  • service de maladies infectieuses et médecine tropicale - Hôpital Pellegrin

    Bordeaux, 33076, France

  • service de médecine inter et maladies infectieuses - Hopital Saint André

    Bordeaux, 33075, France

  • service de médecine interne - CH d'Agen

    Agen, 47923, France

  • service de médecine interne - CH d'Arcachon

    La Teste-de-Buch, 33260, France

  • service de médecine interne - CH d'Orthez

    Orthez, France

  • service de médecine interne - CH de Libourne

    Libourne, 33505, France

  • service de médecine interne et maladies infectieuses - CH de Dax

    Dax, 40107, France

  • service de médecine interne et maladies infectieuses - CH de Pau

    Pau, 64000, France

  • service de médecine interne et maladies infectieuses - CH de Périgueux

    Périgueux, 24019, France

  • service de médecine interne et maladies infectieuses - Groupe hospitalier Sud

    Pessac, France

  • service de médecine interne et maladies infectieuses - Hôpital Saint-André

    Bordeaux, 33075, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.